Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

AM Cornall; M Poljak; SM Garland; S Phillips; JH Tan; DA Machalek; MA Quinn; SN Tabrizi

Journal article

Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

AM Cornall, M Poljak, SM Garland, S Phillips, JH Tan, DA Machalek, MA Quinn, SN Tabrizi

European Journal of Clinical Microbiology & Infectious Diseases | SPRINGER | Published : 2017

DOI: 10.1007/s10096-016-2831-5

University of Melbourne Researchers

Dorothy Machalek Author Melbourne School of Population and Global Health

Alyssa Cornall Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Jeffrey Tan Author Medicine, Dentistry and Health Sciences

Sepehr Tabrizi Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Suzanne Garland Wark Author Obstetrics and Gynaecology Royal Women's Hospital/Mercy

Grants

Funding Acknowledgements

Seegene Inc. supplied the detection kits required for this study. Seegene did not contribute to the design of the study, interpretation of results, or preparation of the manuscript. A member of the Seegene academic team was given the opportunity to comment on technical accuracy of the manuscript related to use of the assay.